Abstract
Sağlıklı yenidoğana sunulan standart izlem ve bakımdan daha fazlasına ihtiyaç duyan, gestasyon haftası ve doğum ağırlığına bakılmaksızın mortalite ve morbidite riski fazla olan yenidoğanlar yüksek riskli yenidoğan olarak tanımlanmaktadır. Ülkemizde perinatal ve neonatal bakım alanındaki gelişmelere paralel olarak yüksek riskli yenidoğanların hayatta kalma oranı artmış, beraberinde bu bebeklerde görülen morbidite ve kronik hastalık oranı da artmıştır. Perinatal risk faktörleri ve yenidoğan döneminde karşılaşılan sorunlar ileri dönemde nörolojik ve gelişimsel gerilik ve problemlerin oluşumuna zemin hazırlamaktadır. Yaşama yüksek risk düzeyi ile başlayan bu çocuklarda serebral palsi, körlük, sağırlık, öğrenme güçlüğü ve davranış bozukluğu gibi sorunlara görülebilmektedir. Sağlıklı bebeklerin izlemi ile ilgili çok sayıda protokol bulunmakla birlikte yüksek riskli bebeklerin uzun süreli izleminin nasıl olması gerektiği ile ilgili yeterli veri yoktur.
References
- 1. Villar J, Giuliani F, Bhutta ZA, et al; International Fetal and Newborn Growth Consortium for the 21(st) Century (INTERGROWTH-21(st)). Postnatal growth standards for preterm infants: the Preterm Postnatal Follow-up Study of the INTERGROWTH-21(st) Project. Lancet Glob Health. 2015;3(11):e681-e691.
- 2. Griffin IJ. Growth management in premature infants. In Uptodate, Abrams SA, Motil KJ (Eds), UpToDate, Wolters Kluwer, 2017.
- 3. Ruys CA, van de Lagemaat M, Finken MJ, Lafeber HN. Follow-up of a randomized trial on postdischarge nutrition in preterm-born children at age 8 y. Am J Clin Nutr. 2017 Aug;106(2):549-558. doi: 10.3945/ajcn.116.145375. Epub 2017 Jun 21. PMID: 28637773.
- 4. Cormack BE, Harding JE, Miller SP, Bloomfield FH. The Influence of Early Nutrition on Brain Growth and Neurodevelopment in Extremely Preterm Babies: A Narrative Review. Nutrients. 2019 Aug 30;11(9):2029. doi: 10.3390/nu11092029. PMID: 31480225; PMCID: PMC6770288.
- 5. Adcock LM, Freysdottir D. Screening the newborn for hearing loss. In: Uptodate, Erişi tarihi: Mart 2022
- 6. Abrams SA, Duryea TK (Eds), UpToDate, Wolters Kluwer, 2017.
- 7. Türkiye Cumhuriyeti Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü Ulusal Yenidoğan İşitme Taraması Uygulama Rehberi, 2017.
- 8. Sankar MJ, Sankar J, Mehta M, Bhat V, Srinivasan R. Anti-vascular endothelial growth factor (VEGF) drugs fortreatment of retinopathy of prematurity. Cochrane Database of Systematic Reviews 2016, Issue 2. Art. No.:CD009734.DOI:10.1002/14651858.CD009734.pub2
Abstract
References
- 1. Villar J, Giuliani F, Bhutta ZA, et al; International Fetal and Newborn Growth Consortium for the 21(st) Century (INTERGROWTH-21(st)). Postnatal growth standards for preterm infants: the Preterm Postnatal Follow-up Study of the INTERGROWTH-21(st) Project. Lancet Glob Health. 2015;3(11):e681-e691.
- 2. Griffin IJ. Growth management in premature infants. In Uptodate, Abrams SA, Motil KJ (Eds), UpToDate, Wolters Kluwer, 2017.
- 3. Ruys CA, van de Lagemaat M, Finken MJ, Lafeber HN. Follow-up of a randomized trial on postdischarge nutrition in preterm-born children at age 8 y. Am J Clin Nutr. 2017 Aug;106(2):549-558. doi: 10.3945/ajcn.116.145375. Epub 2017 Jun 21. PMID: 28637773.
- 4. Cormack BE, Harding JE, Miller SP, Bloomfield FH. The Influence of Early Nutrition on Brain Growth and Neurodevelopment in Extremely Preterm Babies: A Narrative Review. Nutrients. 2019 Aug 30;11(9):2029. doi: 10.3390/nu11092029. PMID: 31480225; PMCID: PMC6770288.
- 5. Adcock LM, Freysdottir D. Screening the newborn for hearing loss. In: Uptodate, Erişi tarihi: Mart 2022
- 6. Abrams SA, Duryea TK (Eds), UpToDate, Wolters Kluwer, 2017.
- 7. Türkiye Cumhuriyeti Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü Ulusal Yenidoğan İşitme Taraması Uygulama Rehberi, 2017.
- 8. Sankar MJ, Sankar J, Mehta M, Bhat V, Srinivasan R. Anti-vascular endothelial growth factor (VEGF) drugs fortreatment of retinopathy of prematurity. Cochrane Database of Systematic Reviews 2016, Issue 2. Art. No.:CD009734.DOI:10.1002/14651858.CD009734.pub2
Details
| Primary Language | Turkish |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Konuşmacı Metinleri |
| Authors | |
| Publication Date | June 30, 2022 |
| Submission Date | March 25, 2022 |
| Acceptance Date | March 25, 2022 |
| Published in Issue | Year 2022 Volume: 15 Issue: (Özel Sayı-1) 21. Mersin Pediatri Günleri Bildiri Kitabı |
Cite
MEU Journal of Health Sciences Assoc was began to the publishing process in 2008 under the supervision of Assoc. Prof. Gönül Aslan, Editor-in-Chief, and affiliated to Mersin University Institute of Health Sciences. In March 2015, Prof. Dr. Caferi Tayyar Şaşmaz undertook the Editor-in Chief position and since then he has been in charge.
Publishing in three issues per year (April - August - December), it is a multisectoral refereed scientific journal. In addition to research articles, scientific articles such as reviews, case reports and letters to the editor are published in the journal. Our journal, which has been published via e-mail since its inception, has been published both online and in print. Following the Participation Agreement signed with TÜBİTAK-ULAKBİM Dergi Park in April 2015, it has started to accept and evaluate online publications.
Mersin University Journal of Health Sciences have been indexed by Turkey Citation Index since November 16, 2011.
Mersin University Journal of Health Sciences have been indexed by ULAKBIM Medical Database from the first issue of 2016.
Mersin University Journal of Health Sciences have been indexed by DOAJ since October 02, 2019.
Article Publishing Charge Policy: Our journal has adopted an open access policy and there is no fee for article application, evaluation, and publication in our journal. All the articles published in our journal can be accessed from the Archive free of charge.
This work is licensed with Attribution-NonCommercial 4.0 International.